IRIS
RUGGIERI, Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.486
AS - Asia 2.161
EU - Europa 1.615
SA - Sud America 576
AF - Africa 96
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.409
SG - Singapore 1.014
CN - Cina 532
BR - Brasile 504
HK - Hong Kong 287
SE - Svezia 286
IT - Italia 271
RU - Federazione Russa 252
DE - Germania 203
UA - Ucraina 202
VN - Vietnam 125
FI - Finlandia 119
GB - Regno Unito 102
CI - Costa d'Avorio 62
FR - Francia 60
IN - India 48
CA - Canada 43
BD - Bangladesh 32
JP - Giappone 23
MX - Messico 22
AR - Argentina 21
ID - Indonesia 21
BE - Belgio 18
ES - Italia 18
PL - Polonia 18
IE - Irlanda 16
AT - Austria 13
IQ - Iraq 12
VE - Venezuela 12
ZA - Sudafrica 12
EC - Ecuador 11
TR - Turchia 11
LT - Lituania 9
PH - Filippine 9
CO - Colombia 8
IR - Iran 8
KE - Kenya 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 6
NL - Olanda 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
IL - Israele 5
CH - Svizzera 4
CL - Cile 4
JM - Giamaica 4
OM - Oman 4
PE - Perù 4
SA - Arabia Saudita 4
TN - Tunisia 4
AU - Australia 3
DK - Danimarca 3
MA - Marocco 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TH - Thailandia 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.940
Salva come PNG Salva come JPEG
Città #
Ashburn 528
Chandler 522
Singapore 519
Fairfield 500
Woodbridge 473
Jacksonville 454
Hong Kong 287
Houston 263
Nyköping 220
Ann Arbor 214
Wilmington 198
Seattle 182
Cambridge 171
Beijing 166
Lawrence 106
Roxbury 103
Nanjing 102
Los Angeles 101
Bari 74
New York 74
Dallas 72
Des Moines 69
Boardman 68
Abidjan 62
Chicago 53
Munich 48
Brooklyn 44
Buffalo 42
Inglewood 42
Princeton 40
Ho Chi Minh City 37
São Paulo 34
Marseille 31
Santa Clara 31
Salt Lake City 28
San Diego 28
Nanchang 25
Hanoi 23
Jiaxing 23
Shenyang 23
Moscow 21
Rio de Janeiro 21
Tokyo 21
Tianjin 20
Brussels 18
Hebei 18
Belo Horizonte 17
Dublin 16
Helsinki 16
Toronto 16
Jakarta 15
Warsaw 15
Miami 14
Chennai 13
Dearborn 13
Mottola 12
Nuremberg 12
Phoenix 12
Frankfurt am Main 11
London 11
Norwalk 11
Pune 11
Stockholm 11
Tampa 11
Augusta 10
Council Bluffs 10
Dong Ket 10
Guangzhou 10
Mexico City 10
Milan 10
San Francisco 10
Assisi 9
Changsha 9
Elk Grove Village 9
Imbersago 9
Johannesburg 9
Montreal 9
Rome 9
Bacolod City 8
Denver 8
Nairobi 8
Paris 8
Tashkent 8
Turku 8
Auburn Hills 7
Boston 7
Campinas 7
Curitiba 7
Monmouth Junction 7
North Bergen 7
Orem 7
Poplar 7
Porto Alegre 7
Salvador 7
Shanghai 7
Bisceglie 6
Brasília 6
Da Nang 6
Dhaka 6
Edmonton 6
Totale 6.724
Salva come PNG Salva come JPEG
Nome #
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study 246
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 186
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 160
Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity. 159
Age-related changes of serum N-acetyl-aspartate in healthy controls. 148
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 145
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 139
Development of an aquaporin-4 orthogonal array of particle-based ELISA for neuromyelitis optica autoantibodies detection 139
Glatiramer Acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from Multiple Sclerosis patients 137
Host-Cell Type Dependent Features of Recombinant Human Aquaporin-4 Orthogonal Arrays of Particles-New Insights for Structural and Functional Studies 136
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 135
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of Multiple Sclerosis 135
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 132
IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism 131
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis. 129
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis 128
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 127
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 120
ANTINFLAMMATORY EFFECTS OF RIFNB-1B IN MULTIPLE SCLEROSIS: LONGITUDINAL CHANGES OF THE SERUM SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1), TNFA AND T-CELL SUBSETS 120
Serum levels of N-acetylaspartate in Huntington's disease: Preliminary results. 116
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 110
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels 110
A population-based surveillance Italian study of Interferon beta treatment in Multiple Sclerosis patients: relationships between neutralizing antibodies production and clinical outcomes 109
Cerebrospinal fluid analysis and the determination of oligoclonal bands 108
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis. 107
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 107
Serum levels of N-acetyl-aspartate in migraine and tension-type headache. 104
CHANGES OF NAIVE AND EFFECTOR/MEMORY T-CELL SUBSETS AND SERUM SOLUBLE ICAM-1 INDUCED BY RIFNB-1B IN MS 103
Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding 102
Serum levels of N-acetyl-aspartate in migraine and tension-type headache. 100
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. 100
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 100
Neurofilament ELISA validation 99
Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica 98
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 97
B and T Immunoregulation: A New Insight of B Regulatory Lymphocytes in Autism Spectrum Disorder 97
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients 96
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 95
Beta Amyloid 1-40 peptide selectively downregulates MMP-9 production in differentiated SH-SY5Y neuronal cell line 95
Italian studies on early-onset multiple sclerosis: the present and the future 92
A LONGITUDINAL ANALYSIS OF SERUM SOLUBLE ICAM-1 (SICAM-1), TNFA AND T-CELL SUBSETS IN MULTIPLE SCLEROSIS (MS) PATIENTS DURING RIFNB-1B TREATMENT 91
Antinflammatory effects of rIFNb-1b in multiple sclerosis: longitudinal changes of the serum soluble Intercellular Adhesion Molecule-1 (sICAM-1), TNFa and T-cell subsets 91
Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy 91
Correlations between neutralizing antibodies production and clinical outcomes: analysis in a population-based surveillance italian study of interferon beta treatment in multiple sclerosis patients 90
Analisi fenotipica di linfociti T di pazienti con Sclerosi Multipla (SM) nel sangue periferico ed in coltura con e senza aggiunta di mitogeni 90
Serum Soluble ICAM-1 and Gelatinase B Novel Markers of Clinical Efficacy of the RIFN-beta-1b in Relapsing-Remitting Multiple Sclerosis 90
Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients 89
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 89
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 88
MMP-9 and 2 activities and TIMPs in MS: differences between early and chronic disease 87
Glatiramer acetate in multiple sclerosis: a review 86
ANALISI DEL POLIMORFISMO GENICO E DELLA PRODUZIONE LIMFOMONOCITARIA DI TNF-ALPHA IN PAZIENTI CON SCLEROSI MULTIPLA (SM) 85
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 85
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 82
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method 81
Serum MMPs and TIMPs in Multiple Sclerosis: differences between early and chronic disease 80
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 79
Neutralizing antibodies during treatment of relapsing Multiple Sclerosis patients with three interferon beta: correlation with clinical outcomes 78
Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke 78
UN ANNO DI TRATTAMENTO CON INTERFERONE B-1B INCREMENTA I LIVELLI SIERICI DI SICAM-1 E RIPRISTINA LA FUNZIONE SOPPRESSORIA DEI T-LINFOCITI IN PAZIENTI CON SM RELAPSING-REMITTING 77
Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A 76
N-Acetyl-Aspartate (NAA) and Neurofilament Light-Chain (NF-L) in Biological Fluids as Markers of Neurodegeneration in ALS 76
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 76
Novel anti-inflammatory properties of rIFN-beta-1b in RR MS: recovery of T-suppression and increase of serum sICAM-1 75
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing 74
RIFNB DOWNREGULATES TNFA-INDUCED ICAM-1 EXPRESSION ON BRAIN MICROVASCULAR ENDOTHELIAL CELLS (BEMC) AND INCREASES SERUM SOLUBLE ICAM-1 (SICAM-1) IN RR MS 74
Standard (SD) and triple dose (TD) gadolinium (Gd) enhancing lesions are associated with a similar degree of MMP-9 and TIMP-1 involvement at the blood-brain barrier (BBB) level in Multiple Sclerosis (MS) 74
CHANGES OF SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1) LEVELS INDUCED BY CORTICOSTEROIDS AND RIFN-BETA-1B IN MULTIPLE SCLEROSIS AND GUILLAIN-BARRÉ SYNDROME 73
Bcl-2, Bax, Cytocrome-c mitochondria mediated apoptosis proteins during Glatiramer Acetate treatment in Multiple Sclerosis patients 73
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 72
null 72
LFA-1 expressing CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNb-1a 72
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy 71
null 71
Interferone beta (IFNb) e barriera emato-encefalica nella Sclerosi Multipla: effetto su molecole di adesione e metalloproteasi 71
Modificazioni dei livelli sierici di ICAM-1 solubile (sICAM.1), e Gelatinasi A e B e sottopopolazioni T-linfocitarie di sangue periferico indotte dal trattamento con interferone-beta-1b (IFN-BETA-1B) in pazienti con Sclerosi Multipla (SM) Relapsing-Remitting (RR): Relazione con la produzione di anticorpi neutralizzanti anti-interferone (NABs) 70
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis 69
STUDIO IN VITRO DI POPOLAZIONI LINFOMONOCITARIE CD45R+ E CD29+ 68
Decreased levels of serum gelatinase B in MS patients during the treatment with rIFN-beta-1b 68
LFA-1 EXPRESSION ON CD4+CD45RO+ PBTLS DURING RIFN-BETA-1A TREATMENT IN RR MS: IN VIVO AND IN VITRO STUDY 67
Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies 66
LFA-1 EXPRESSION ON CD4+CD45RO+ PERIPHERAL BLOOD T-LYMPHOCYTES: IN VIVO AND IN VITRO CHANGES INDUCED BY RECOMBINANT INTERFERON-BETA-1A (RIFN-BETA-1A) IN RELAPSING-REMITTING (RR) MULTIPLE SCLEROSIS (MS) 64
Interferon-b treatment in relapsing remitting multiple sclerosis: results of an observational study in southern Italy 64
RIFN BETA-1A AND SICAM-1 EFFECTS ON CD4+CD45RO+ PBTLS EXPRESSING LFA-1 IN RR MS: IN VIVO AND IN VITRO STUDY 62
null 62
Changes of serum soluble ICAM-1 and matrix metalloproteinas-9 (MMP-9) induced by Interferon beta-1b treatment in relapsing-remitting multiple sclerosis 62
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 61
NMO-IgG and AQP-4 antibodies in different demyelinating disease phenotypes: correlations with clinical and paraclinical parameters 61
Changes of serum sICAM-1 and MMP-9 induced by rIFN beta-1b treatment in relapsing-remitting MS 61
SOPLUBLE INTERCELLULAR ADHESION MOLECULE-1 (SICAM-1) NEL SIERO E LIQUOR DI PAZIENTI CON SCLEROSI MULTIPLA REMITTENTE CLINICAMENTE ATTIVA: CORRELAZIONI CON LESIONI RMI CHE ASSUMONO GADOLINIO E CON PARAMETRI LIQUORALI 60
CSF and serum soluble adhesion molecules in Multiple Sclerosis 60
Soluble Intercellular Adhesion Molecule-1 in serum and cerebrospinal fluid of demyelinating disease of the central and peripheral nervous system 59
IFNB-1B TREATMENT EFFECTS ON SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 SERUM LEVELS AND T-CELL SUBSETS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS. 12TH CONGRESS OF THE EUROPEAN COMMITTE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS (ECTRIMS) 58
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes 58
Serum N-acetyl-aspartate in Relapsing Remitting Multiple Sclerosis 57
Matrix metalloproteinases and disease corse in Multiple Sclerosis 57
Phenotype analysis of fresh peripheral blood, unstimulated and stimulated-cultured lymphocytes in Multiple Sclerosis (MS) with different disease course 56
VALUTAZIONE POST-MARKETING DI SICUREZZA DELL' INTERFERONE-BETA (IFN-BETA) IN PAZIENTI CON SCLEROSI MULTIPLA (SM) RELAPSING-REMITTING (RR) NELL' ITALIA MERIDIONALE. RICERCA SCIENTIFICA DELLE 55
MMPS AND TIMPS ARE DIFFERENTLY RELATED TO MS COURSES AND PHASES OF THE DISEASE 55
MMPs and TIMPs involvement at the blood-brain barrier level in MS: comparison between patients enhancing with different doses of gadolinium during rIFNb-1a treatment 55
Totale 9.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021563 0 0 0 0 0 65 108 51 93 122 83 41
2021/2022673 23 111 19 19 25 35 28 42 40 21 135 175
2022/20231.298 172 121 83 133 157 176 11 145 234 1 30 35
2023/2024391 47 70 24 24 24 90 28 21 4 10 3 46
2024/20252.092 62 36 146 55 46 152 155 187 67 129 443 614
2025/20262.158 621 206 286 453 458 134 0 0 0 0 0 0
Totale 10.105